SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200 prescription medications by an average of 40%, with even greater savings available for select medications.

加利福尼亚州圣莫尼卡（BUSINESS WIRE）-古德克斯（纳斯达克股票代码：GDRX）是医疗储蓄和信息的领先资源，今天宣布沃尔格林的一项新举措，将近200种处方药的价格平均降低40%，选择药物可节省更多费用。

Consumers can now purchase many popular prescriptions at Walgreens for less than $15 for a 30-day fill, without any deductibles, restrictions, paperwork, approvals or quantity limitations..

消费者现在可以在Walgreens购买许多流行的处方，为期30天的填充时间少于15美元，没有任何免赔额，限制，文书工作，批准或数量限制。。

The new lower prices include medications for many health concerns, including heart disease and mental health, as well as categories often not covered by insurance, such as acne, insomnia, men’s health, and weight loss.

新的较低价格包括用于许多健康问题的药物，包括心脏病和心理健康，以及通常不包括在保险范围内的类别，如痤疮，失眠，男性健康和体重减轻。

“Americans shouldn’t have to jump through hoops to be able to afford their medications,” said Jim Sheninger, Pharmacy Strategy Officer of GoodRx. “Walgreens has been part of our network since nearly the beginning, enabling us to offer their customers lower prices on the most commonly prescribed medications to make it even easier for people to save money.

GoodRx药房战略官员吉姆·谢宁格（Jim Sheninger）说：“美国人不应该跳过箍就能够负担得起药物。”。“Walgreens几乎从一开始就一直是我们网络的一部分，使我们能够为客户提供最常用处方药的较低价格，使人们更容易省钱。

We believe everyone deserves affordable healthcare, and this initiative will help more Americans access the treatment they need.”.

我们相信每个人都应该负担得起的医疗保健，这一举措将帮助更多的美国人获得他们需要的治疗。

The following is a sample list of the most common prescriptions available now for lower prices at Walgreens with a GoodRx coupon:

以下是目前在Walgreens以较低价格和GoodRx优惠券提供的最常见处方的示例列表：

Medication

用药

Previous Price

以前的价格

Lower Price

价格较低

% Savings

%储蓄

Heart Disease

心脏病

Amlodipine

氨氯地平

$21.83

$21.83

$6.69

$6.69

69%

69%

Lisinopril

赖诺普利

$12.91

$12.91

$7.27

$7.27

44%

44%

Ezetimibe

埃泽替米贝

$34.99

$34.99

$20.51

$20.51

41%

41%

Atorvastatin

阿托伐他汀

$21.99

$21.99

$13.75

$13.75

37%

37%

Men’s Health

男人的健康

Finasteride

非那雄胺

$71.58

$71.58

$16.88

$16.88

76%

76%

Vardenafil

伐地那非

$149.62

$149.62

$38.53

$38.53

74%

74%

Tadalafil (Cialis)

他达拉非（Cialis）

$29.99

$29.99

$16.90

$16.90

44%

44%

Sildenafil

西地那非

$25.99

$25.99

$19.69

$19.69

24%

24%

Mental Health

精神卫生

Escitalopram

Escitalopram

$34.15

$34.15

$14.05

$14.05

59%

59%

Bupropion XL

安非他酮XL

$29.99

$29.99

$15.62

$15.62

48%

48%

Fluoxetine

氟西汀

$25.50

$25.50

$13.49

$13.49

47%

47%

Sertraline

舍曲林

$19.99

$19.99

$13.84

$13.84

31%

31%

For years, GoodRx has provided Walgreens customers with significant cost savings on their medications. Now, for a limited time, medications are even more affordable for the millions of customers Walgreens serves each day at its nearly 9,000 retail locations.

多年来，GoodRx为Walgreens客户提供了大量的药物成本节约。现在，在有限的时间内，Walgreens每天在其近9000个零售地点为数百万客户提供更实惠的药物。

With rising medication prices and high inflation making it difficult for many Americans to manage their healthcare costs, GoodRx aims to make it easier than ever for Walgreens customers to save on prescriptions and adhere to treatment plans.

随着药品价格上涨和高通货膨胀使许多美国人难以管理医疗保健成本，GoodRx的目标是使Walgreens客户比以往任何时候都更容易节省处方并遵守治疗计划。

To search prescription savings at Walgreens and compare prices, consumers can visit www.GoodRx.com/Walgreens.

要在Walgreens搜索处方储蓄并比较价格，消费者可以访问www.GoodRx.com/Walgreens。

About GoodRx

关于GoodRx

GoodRx is a leading resource for healthcare savings and information that makes healthcare affordable and convenient for all Americans. We offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information.

GoodRx是医疗储蓄和信息的领先资源，使所有美国人都能负担得起医疗保健。我们为消费者提供透明和低价格的品牌和仿制药，通过远程医疗提供价格合理方便的医疗服务提供者咨询以及全面的医疗保健研究和信息。

Since 2011, we have helped consumers save over $60 billion and are one of the most downloaded medical apps over the past decade..

自2011年以来，我们帮助消费者节省了超过600亿美元，是过去十年中下载最多的医疗应用之一。。

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts.

GoodRx定期在其投资者关系网站上发布对投资者可能重要的信息https://investors.goodrx.com.我们打算使用我们的网站作为披露材料非公开信息的手段，并遵守我们在FD法规下的披露义务。因此，鼓励投资者和潜在投资者定期咨询GoodRx的网站以获取重要信息，此外还要遵循GoodRx的新闻稿，向证券交易委员会（“SEC”）提交申请以及公开电话和网络广播。

The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release..

包含在GoodRx网站上或可以通过GoodRx网站访问的信息不是通过引用合并到本新闻稿中，也不是本新闻稿的一部分。。

GoodRx Forward-Looking Statements

GoodRx前瞻性声明

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding consumer savings and the benefits of our offerings to consumers and at any pharmacies.

本新闻稿包含1995年“私人证券诉讼改革法”含义内的前瞻性声明。本新闻稿中包含的与历史事实事项无关的所有声明均应视为前瞻性声明，包括但不限于有关消费者储蓄以及我们向消费者和任何药店提供的产品利益的声明。

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits, changes in medication pricing and pricing structures, our reliance on a limited number of industry participants, the competitive nature of our industry, risks related to government regulation of the internet, e-commerce, consumer data and privacy, information technology and cyber-security and the important factors discussed in the sections entitled “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year ended December 31, 2022, as updated by our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, and our other filings with the Securities and Exchange Commission.

这些陈述既不是承诺也不是保证，但涉及已知和未知的风险，不确定性和其他重要因素，这些因素可能导致我们的实际结果，绩效或成就与前瞻性表达或暗示的任何未来结果，绩效或成就有实质性差异。声明，包括但不限于，与我们实现广泛的市场教育和改变消费者购买习惯的能力，药物定价和定价结构的变化，我们对有限数量的行业参与者的依赖，我们行业的竞争性质，与政府监管互联网相关的风险有关的风险，电子商务，消费者数据和隐私，信息技术和网络安全以及GoodRx在2022年12月31日结束的年份表格10-K年度报告中题为“风险因素”的章节中讨论的重要因素，由我们在本季度表格10-Q的季度报告更新截至2023年6月30日，以及我们向证券交易所提交的其他文件。

These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some poi.

这些因素可能导致实际结果与本新闻稿中的前瞻性声明所表明的结果大不相同。截至本新闻稿发布之日，任何此类前瞻性声明均代表管理层的估计。虽然我们可以选择在某些poi上更新此类前瞻性声明。